Speakers

• North America Lead OCT Application Specialist • Expert lecturer on use of OCT, fundus photography and fluorescein angiography • Chaired UNC Kittner Eye Center…

Thomas A. Reh, PhD received his BS in Biochemistry from the University of Illinois, Champaign-Urbana in 1977 and his Ph.D. in Neuroscience from the University…

Dante Pieramici is Director of the California Retina Research Foundation and a Managing Partner of The California Retina Consultants, CA, USA. He is the former…

Since co-founding the company in 2006, Patrick has led the steady growth of the company toward becoming a leading choice for ophthalmology pharmaceutical and biotech…

Daniel A. de Boer is a Dutch serial entrepreneur and the founding Chief Executive Officer of ProQR Therapeutics since the company’s incorporation in 2012. When…

Dr. Mark Wieland is the president of Northern California Retina Vitreous Associates, one of the premier and largest vitreoretinal practices in the Bay Area. He…

Dr. Csaky’s main areas of interest are studying both clinical research and drug delivery development as it pertains to retinal diseases. In particular Dr. Csaky…

Dr. Grunberg is a Managing Director of Longitude Capital. Prior to joining Longitude Capital in 2012, Dr. Grunberg was a Principal at Rho Ventures and…

Dr. David Kirn a clinician-scientist, senior biotechnology, and entrepreneur who has extensive expertise in the areas of design, clinical research, and development of oncolytic viruses,…

Dr. Pinakin Davey is a tenured Professor and Director of Research at Western University of Health Sciences, College of Optometry. He holds Doctor of Optometry…